Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNTX Context Therapeutics Inc.

已收盘 09-25 16:00:00 EDT

0.3457

-0.0254

-6.84%

盘后0.3500

+0.0043+1.24%

19:48 EDT

最高0.3802	最低0.3445	成交量132.54万
今开0.3712	昨收0.3711	日振幅9.63%
总市值3,176万	流通市值2,203万	总股本9,188万
成交额46.61万	换手率2.08%	流通股本6,373万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNTX","market":"US","secType":"STK","nameCN":"Context Therapeutics Inc.","latestPrice":0.3457,"timestamp":1790366400000,"preClose":0.3711,"halted":0,"volume":1325377,"hourTrading":{"tag":"盘后","latestPrice":0.35,"preClose":0.3457,"latestTime":"19:48 EDT","volume":18956,"amount":6601.7987,"timestamp":1790380081094,"change":0.0043,"changeRate":0.012439,"amplitude":0.022563},"delay":0,"changeRate":-0.06844516302883315,"floatShares":63733600,"shares":91879177,"eps":-0.482831,"marketStatus":"已收盘","change":-0.0254,"latestTime":"09-25 16:00:00 EDT","open":0.3712,"high":0.380229,"low":0.3445,"amount":466085.05791825004,"amplitude":0.096279,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.482831,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1790582400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1634702400000,"exchange":"NASDAQ","adjPreClose":0.3711,"preHourTrading":{"tag":"盘前","latestPrice":0.3863,"preClose":0.3711,"latestTime":"09:22 EDT","volume":643,"amount":243.96710501,"timestamp":1790342551998,"change":0.0152,"changeRate":0.040959,"amplitude":0.069254},"postHourTrading":{"tag":"盘后","latestPrice":0.35,"preClose":0.3457,"latestTime":"19:48 EDT","volume":18956,"amount":6601.7987,"timestamp":1790380081094,"change":0.0043,"changeRate":0.012439,"amplitude":0.022563},"volumeRatio":1.469535},"requestUrl":"/m/hq/s/CNTX","defaultTab":"news","newsList":[{"id":"1137664043","title":"Context Therapeutics公布Proc患者确认总缓解率达29%，中位既往治疗线数为7","url":"https://stock-news.laohu8.com/highlight/detail?id=1137664043","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137664043?lang=zh_cn&edition=full","pubTime":"2026-06-15 18:31","pubTimestamp":1781519478,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc. 公布了一项临床试验数据，显示在Proc患者中，经确认的总体缓解率达到29%。值得注意的是，这些患者先前接受过的治疗中位数为7种。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102394348","title":"Context Therapeutics公布CTIM-76一期临床试验中期积极疗效与安全性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1102394348","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102394348?lang=zh_cn&edition=full","pubTime":"2026-06-15 18:30","pubTimestamp":1781519418,"startTime":"0","endTime":"0","summary":"Context Therapeutics公司宣布，其正在进行的CTIM-76一期临床试验取得了积极的中期疗效和安全性结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144105280","title":"Context Therapeutics修订协议，彻底免除CT-202未来里程碑付款与特许权使用费义务","url":"https://stock-news.laohu8.com/highlight/detail?id=1144105280","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144105280?lang=zh_cn&edition=full","pubTime":"2026-05-18 18:47","pubTimestamp":1779101240,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc.宣布，已成功修订其关于药物CT-202的许可协议。根据修订条款，公司未来所有与此药物相关的里程碑付款及特许权使用费义务均被完全免除。此项调整显著优化了公司的财务结构，移除了潜在的长期现金流支出，为未来的研发与运营提供了更大的财务灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTX","BK4007","BCAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139235650","title":"Context Therapeutics持有5450万美元现金及等价物 预计可维持运营至2027年中","url":"https://stock-news.laohu8.com/highlight/detail?id=1139235650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139235650?lang=zh_cn&edition=full","pubTime":"2026-05-07 04:24","pubTimestamp":1778099074,"startTime":"0","endTime":"0","summary":"截至2026年3月31日，生物制药公司Context Therapeutics Inc.宣布其现金及现金等价物储备达5450万美元。这一资金规模预计将为公司核心运营提供充足支持，使其能够持续开展研发活动至2027年中期。该公司目前专注于肿瘤治疗领域创新药物的开发。资本市场分析师指出，此类资金储备公告往往预示着企业具备应对研发周期波动的能力。对于生物科技公司而言，维持18个月以上的运营资金缓冲是评估其研发可持续性的关键指标之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120227939","title":"Context Therapeutics宣布CTIM-76获FDA快速通道资格，用于治疗铂类耐药卵巢癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1120227939","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120227939?lang=zh_cn&edition=full","pubTime":"2026-04-02 19:31","pubTimestamp":1775129473,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc.近日宣布，其研发的CTIM-76已获得美国食品药品监督管理局（FDA）授予的快速通道资格，该药物将用于治疗铂类耐药卵巢癌患者。这一重要进展有望加速CTIM-76的临床开发与审评进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184047367","title":"Context Therapeutics：截至2025年12月31日持有6600万美元现金及等价物，预计可支撑运营至2027年中","url":"https://stock-news.laohu8.com/highlight/detail?id=1184047367","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184047367?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:18","pubTimestamp":1774297095,"startTime":"0","endTime":"0","summary":"生物制药公司Context Therapeutics Inc.最新财务数据显示，截至2025年12月31日，公司持有的现金及现金等价物总额达6600万美元。基于当前运营规划与资金消耗速率测算，这笔资金预计足以支持公司日常运营及研发活动持续至2027年中期。这一资金储备为Context Therapeutics推进其临床阶段肿瘤创新疗法提供了重要财务保障。稳定的资金支持对生物科技企业的长期发展至关重要。Context Therapeutics通过战略性资金管理，为未来两年的研发进程奠定了坚实基础，展现出持续推动创新疗法上市的财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165513","title":"Context Therapeutics Inc.盘中异动 早盘急速上涨6.89%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517165513?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271534,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Context Therapeutics Inc.股票出现波动，股价快速上涨6.89%。截至发稿，该股报0.900美元/股，成交量9448股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为954.97%、104.38%、49.12%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223215abeb77cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223215abeb77cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514486746","title":"Context Therapeutics Inc.盘中异动 快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514486746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514486746?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:00","pubTimestamp":1740603608,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日05时00分，Context Therapeutics Inc.股票出现波动，股价急速拉升5.10%。截至发稿，该股报0.856美元/股，成交量6.3169万股，换手率0.08%，振幅4.95%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227050008abde40d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227050008abde40d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513129634","title":"Context Therapeutics Inc.盘中异动 早盘快速拉升7.47%报0.849美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513129634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513129634?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148273,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Context Therapeutics Inc.股票出现异动，股价快速上涨7.47%。截至发稿，该股报0.849美元/股，成交量5962股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.02%、60.21%、17.19%，振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为11.30%、10.21%、7.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223113abd7af45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223113abd7af45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512649561","title":"Context Therapeutics Inc.盘中异动 快速拉升6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512649561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512649561?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:52","pubTimestamp":1739893965,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时52分，Context Therapeutics Inc.股票出现波动，股价大幅上涨6.13%。截至发稿，该股报0.872美元/股，成交量1.2219万股，换手率0.02%，振幅2.56%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235245abd3c187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235245abd3c187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CNTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509206743","title":"Context Therapeutics Inc.盘中异动 临近午盘快速下挫5.20%报0.907美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509206743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509206743?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:32","pubTimestamp":1738859553,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时32分，Context Therapeutics Inc.股票出现异动，股价急速下挫5.20%。截至发稿，该股报0.907美元/股，成交量3.5707万股，换手率0.05%，振幅7.54%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003233a23be88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003233a23be88c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CNTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509280445","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509280445?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:17","pubTimestamp":1738768654,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时17分，Context Therapeutics Inc.股票出现波动，股价急速上涨9.02%。截至发稿，该股报0.958美元/股，成交量1946股，换手率0.00%，振幅4.99%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3901.91%、1140.99%、671.38%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231734abc387d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231734abc387d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508290450","title":"Context Therapeutics Inc.盘中异动 快速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508290450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508290450?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:53","pubTimestamp":1738680817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时53分，Context Therapeutics Inc.股票出现波动，股价急速拉升5.52%。截至发稿，该股报0.920美元/股，成交量1793股，换手率0.00%，振幅1.14%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1307.05%、823.17%、199.89%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025、Invivyd, Inc.，振幅分别为49.48%、40.00%、29.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225337987a4e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225337987a4e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507679910","title":"Context Therapeutics Inc.盘中异动 股价大涨6.05%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507679910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507679910?lang=zh_cn&edition=full","pubTime":"2025-01-31 01:57","pubTimestamp":1738259870,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日01时57分，Context Therapeutics Inc.股票出现异动，股价快速上涨6.05%。截至发稿，该股报0.870美元/股，成交量8.5836万股，换手率0.11%，振幅4.83%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Nutriband Inc C/Wts 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1749.47%、272.95%、233.36%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131015750a2347791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131015750a2347791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506301496","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨5.20%报0.949美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506301496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506301496?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:04","pubTimestamp":1737993896,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时04分，Context Therapeutics Inc.股票出现异动，股价快速上涨5.20%。截至发稿，该股报0.949美元/股，成交量5172股，换手率0.01%，振幅4.52%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1968.51%、454.97%、218.26%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为86.84%、85.35%、65.16%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128000456abba74b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128000456abba74b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505012557","title":"Context Therapeutics Inc.盘中异动 快速拉升6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505012557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505012557?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:01","pubTimestamp":1737644476,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时01分，Context Therapeutics Inc.股票出现波动，股价快速拉升6.60%。截至发稿，该股报1.000美元/股，成交量1.8867万股，换手率0.03%，振幅0.01%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230117abb600e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230117abb600e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503422990","title":"Context Therapeutics Inc.盘中异动 股价大涨5.08%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503422990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503422990?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:30","pubTimestamp":1737037859,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时30分，Context Therapeutics Inc.股票出现异动，股价大幅上涨5.08%。截至发稿，该股报1.030美元/股，成交量4745股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622305998688b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622305998688b65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503647063","title":"Context Therapeutics Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503647063?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:30","pubTimestamp":1736951447,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时30分，Context Therapeutics Inc.股票出现异动，股价快速拉升5.03%。截至发稿，该股报1.040美元/股，成交量7.4565万股，换手率0.10%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Eterna Therapeutics Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.10%、52.56%、49.47%，振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Cibus, Inc.，振幅分别为10.37%、9.31%、7.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223047a222fd4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223047a222fd4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501778736","title":"Context Therapeutics Inc.盘中异动 早盘大幅上涨8.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501778736?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:31","pubTimestamp":1736346682,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时31分，Context Therapeutics Inc.股票出现波动，股价急速拉升8.26%。截至发稿，该股报1.18美元/股，成交量2.6059万股，换手率0.03%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223122a21a526b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223122a21a526b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500119261","title":"Context Therapeutics Inc.盘中异动 早盘快速拉升8.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500119261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500119261?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914708,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Context Therapeutics Inc.股票出现波动，股价急速上涨8.40%。截至发稿，该股报1.29美元/股，成交量5953股，换手率0.01%，振幅0.84%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223148ab9d5a57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223148ab9d5a57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CNTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contexttherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0321},{"period":"1month","weight":-0.1477},{"period":"3month","weight":-0.3602},{"period":"6month","weight":-0.8567},{"period":"1year","weight":-0.6109},{"period":"ytd","weight":-0.7476}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Context Therapeutics Inc.于2015年4月在特拉华州成立。该公司是一家临床阶段的生物制药公司，致力于推进用于实体瘤的T细胞衔接双特异性抗体。其研发管线包括靶向CLDN6的CTIM-76、靶向间皮素的CT-95以及靶向Nectin-4的CT-202，这些候选药物正在进行或计划进行1期临床试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.188281},{"month":2,"riseRate":0.2,"avgChangeRate":-0.080088},{"month":3,"riseRate":0.6,"avgChangeRate":-0.010229},{"month":4,"riseRate":0.4,"avgChangeRate":-0.001309},{"month":5,"riseRate":0.8,"avgChangeRate":0.277604},{"month":6,"riseRate":0.6,"avgChangeRate":0.025564},{"month":7,"riseRate":0.6,"avgChangeRate":-0.029484},{"month":8,"riseRate":0.6,"avgChangeRate":-0.023714},{"month":9,"riseRate":0.4,"avgChangeRate":-0.009484},{"month":10,"riseRate":0.75,"avgChangeRate":0.018618},{"month":11,"riseRate":0.6,"avgChangeRate":-0.036732},{"month":12,"riseRate":0.4,"avgChangeRate":-0.161685}],"exchange":"NASDAQ","name":"Context Therapeutics Inc.","nameEN":"Context Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Context Therapeutics Inc.,CNTX,Context Therapeutics Inc.股票,Context Therapeutics Inc.股票老虎,Context Therapeutics Inc.股票老虎国际,Context Therapeutics Inc.行情,Context Therapeutics Inc.股票行情,Context Therapeutics Inc.股价,Context Therapeutics Inc.股市,Context Therapeutics Inc.股票价格,Context Therapeutics Inc.股票交易,Context Therapeutics Inc.股票购买,Context Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}